CODX
Co-Diagnostics, Inc. Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$5.19M
P/E Ratio
—
EPS
$-35.25
Beta
1.43
52W High
$46.50
52W Low
$1.35
50-Day MA
$2.38
200-Day MA
$7.69
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
15.36
PEG Ratio
0.00
About Co-Diagnostics, Inc. Common Stock
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | 622,490 |
| Gross Profit (TTM) | 400,110 |
| EBITDA | $-30.18M |
| Operating Margin | -2902.00% |
| Return on Equity | -125.90% |
| Return on Assets | -44.30% |
| Revenue/Share (TTM) | $0.47 |
| Book Value | $9.85 |
| Price-to-Book | 0.16 |
| Price-to-Sales (TTM) | 8.33 |
| EV/Revenue | 5.03 |
| EV/EBITDA | 0.52 |
| Quarterly Earnings Growth (YoY) | 30.80% |
| Quarterly Revenue Growth (YoY) | 76.70% |
| Shares Outstanding | $3.60M |
| Float | $3.50M |
| % Insiders | 0.00% |
| % Institutions | 4.04% |
Data last updated: 4/10/2026